Advanced Pancreatic Cancer
53
8
12
18
Key Insights
Highlights
Success Rate
90% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
3.8%
2 terminated out of 53 trials
90.0%
+3.5% vs benchmark
8%
4 trials in Phase 3/4
17%
3 of 18 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 18 completed trials
Clinical Trials (53)
A Study to Evaluate the Safety and Tolerability of AB680 in Participants With Gastrointestinal Malignancies
ProAgio in Previously Treated Advanced Pancreatic Cancer and Other Solid Tumor Malignancies
Profiling Program of Advanced/Metastatic Pancreatic Cancer Patients
Clinical Study Evaluating the Safety, Tolerability, and Preliminary Efficacy of LM-108 ± Penpulimab+Chemotherapy in Advanced Solid Tumors - Cohort C
Recombinant Human IL-21-expressing Oncolytic Vaccinia Virus Injection (hV01) in Advanced Pancreatic Cancer
Pancreatic Adenocarcinoma Signature Stratification for Treatment
Exploratory Clinical Study of Claudin18.2-Targeted Activated DC and CAR-T Therapy in Advanced Pancreatic Cancer.
APG-1387 Plus Chemotherapy in Advanced Pancreatic Adenocarcinoma
Phase IB Metformin, Digoxin, Simvastatin in Solid Tumors
A Study Comparing MRG004A Plus Best Supportive Care Versus Placebo and Best Supportive Care in the Treatment of Patients With Advanced Pancreatic Cancer
1911GCCC: Galeterone With Gemcitabine for Patients With Metastatic Pancreatic Adenocarcinoma
A Real-world Study of Liposomal Irinotecan (Onivyde)-Based Therapy in Patients With Locally Advanced/Metastatic Pancreatic Cancer in China
A Clinical Study to Evaluate the Safety and Tolerability of JS107 in Advanced Pancreatic Cancer
A Study of Armed, Activated T-Cells in Patients With Advanced Pancreatic Cancer
Statin Addition to Chemotherapy for Advanced Pancreatic Cancer
A Study of Irinotecan Liposome in Advanced Pancreatic Cancer
Erlotinib, Gemcitabine and Nab-Paclitaxel in Advanced Pancreatic Cancer
A Study of Fluzoparib in Combination With mFOLFIRINOX in Patients With Advanced Pancreatic Cancer
A Study of Cabiralizumab Given With Nivolumab With and Without Chemotherapy in Patients With Advanced Pancreatic Cancer
A Study of Docetaxel for Injection (Albumin Bound) in Patients With Advanced Pancreatic Cancer